| 1 |
34871862 | miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux. | 2022 Jan |
1 |
| 2 |
33493421 | Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis. | 2021 Jan 25 |
3 |
| 3 |
33502419 | Microfluidic studies of hydrostatic pressure-enhanced doxorubicin resistance in human breast cancer cells. | 2021 Feb 23 |
1 |
| 4 |
33775688 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. | 2021 May 1 |
1 |
| 5 |
34096893 | Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia. | 2021 Jul 1 |
1 |
| 6 |
34415509 | Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance. | 2021 Sep |
1 |
| 7 |
34552008 | Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. | 2021 Dec |
1 |
| 8 |
34848465 | Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells. | 2021 Dec |
1 |
| 9 |
34869595 | Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells. | 2021 |
2 |
| 10 |
32010961 | Germline variant burden in multidrug resistance transporters is a therapy-specific predictor of survival in breast cancer patients. | 2020 May 1 |
1 |
| 11 |
32241443 | Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer. | 2020 Jun 1 |
2 |
| 12 |
32278855 | miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells. | 2020 Jul 5 |
1 |
| 13 |
32340377 | Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells. | 2020 Apr 23 |
4 |
| 14 |
32606732 | CircFoxo3 Promotes Adriamycin Resistance Through Regulation of miR-199a-5p/ATP Binding Cassette Subfamily C Member 1 Axis in Hepatocellular Carcinoma. | 2020 |
1 |
| 15 |
32712543 | The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes. | 2020 Oct |
1 |
| 16 |
30609135 | Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro. | 2019 Jan 4 |
2 |
| 17 |
30945389 | Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer. | 2019 Jun |
1 |
| 18 |
31009836 | Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines. | 2019 May |
3 |
| 19 |
31043590 | Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia. | 2019 May 1 |
1 |
| 20 |
31401398 | Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents. | 2019 Oct |
3 |
| 21 |
31646427 | Encapsulation of crocetin into poly (lactic-co-glycolic acid) nanoparticles overcomes drug resistance in human ovarian cisplatin-resistant carcinoma cell line (A2780-RCIS). | 2019 Dec |
1 |
| 22 |
31704984 | Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells. | 2019 Nov 8 |
1 |
| 23 |
29445446 | Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1. | 2018 |
1 |
| 24 |
29463376 | Ciclosporin A as a Reversal Agent Against Concurrent Multidrug Resistance in Tumors with Nanobubbles. | 2018 Jan 1 |
1 |
| 25 |
29475141 | Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. | 2018 Apr |
2 |
| 26 |
29541235 | Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro. | 2018 Apr |
2 |
| 27 |
29615646 | Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells. | 2018 Apr 3 |
4 |
| 28 |
29747752 | Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. | 2018 Apr 1 |
2 |
| 29 |
30037815 | Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma. | 2018 Nov 1 |
4 |
| 30 |
30188727 | Programmable Metal/Semiconductor Nanostructures for mRNA-Modulated Molecular Delivery. | 2018 Oct 10 |
2 |
| 31 |
30232176 | Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells. | 2018 Dec |
1 |
| 32 |
30466628 | Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA. | 2018 Dec 1 |
3 |
| 33 |
30486290 | Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. | 2018 Nov 26 |
1 |
| 34 |
27250110 | Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. | 2017 Jun |
1 |
| 35 |
27822706 | Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma. | 2017 Feb |
2 |
| 36 |
27878697 | NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer. | 2017 Jul |
2 |
| 37 |
28214549 | ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells. | 2017 May |
3 |
| 38 |
28258008 | High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1). | 2017 May |
2 |
| 39 |
28711493 | Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells. | 2017 Sep 9 |
1 |
| 40 |
28762597 | Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1. | 2017 Oct |
1 |
| 41 |
28881292 | Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1. | 2017 Nov |
1 |
| 42 |
29069754 | LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. | 2017 Sep 22 |
2 |
| 43 |
29085470 | Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line. | 2017 Oct |
3 |
| 44 |
29104509 | Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway. | 2017 |
1 |
| 45 |
26548759 | Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. | 2016 |
1 |
| 46 |
26722004 | Localization of MRP-1 to the outer mitochondrial membrane by the chaperone protein HSP90β. | 2016 May |
5 |
| 47 |
27476287 | SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES. | 2016 May-Jun |
1 |
| 48 |
27487127 | miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1. | 2016 Sep 13 |
6 |
| 49 |
27731405 | Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. | 2016 Oct 12 |
2 |
| 50 |
28276667 | Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion. | 2016 Mar |
1 |